Utama › Limfoma Zon Tepi › Maryland

Kajian klinikal Limfoma Zon Tepi di Maryland

6 kajian untuk Limfoma Zon Tepi sedang mencari peserta di lokasi di Maryland.

Teks kajian rasmi (Bahasa Inggeris)

A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies

American Oncology Partners of Maryland Pa, Bethesda

Mengambil pesertaFasa 1/2

Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT05006716

Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Lymphoplasmacytic Lymphoma (LPL)/Waldenstrom Macroglobulinemia (WM), and Splenic Marginal Zone Lymphoma (SMZL)

National Institutes of Health Clinical Center, Bethesda

Mengambil pesertaKajian pemerhatian

Umur 18 hingga 110 · Semua jantina · Dikemas kini 28 Sep 2026 · NCT00923507

A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

National Institute of Health, Bethesda

Mengambil pesertaFasa 1

Umur 18 ke atas · Semua jantina · Dikemas kini 2 Jul 2026 · NCT05131022

A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies

National Institutes of Health Clinical Center, Bethesda

Mengambil pesertaFasa 1

Umur 18 ke atas · Semua jantina · Dikemas kini 20 Mac 2026 · NCT04830137

AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma

University of Maryland Medical Center - Greenebaum Comprehensive Cancer Center, Baltimore

Mengambil pesertaFasa 1

Umur 18 ke atas · Semua jantina · Dikemas kini 10 Dis 2025 · NCT05602363

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Massive Bio SYNERGY-AI site, Baltimore
Massive Bio SYNERGY-AI site, Bethesda
Massive Bio SYNERGY-AI site, Silver Spring
dan 1 lagi

Mengambil pesertaKajian pemerhatian

Semua umur · Semua jantina · Dikemas kini 28 Okt 2025 · NCT03452774

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.